Joanna Horobin's Insider Trades & SAST Disclosures

Joanna Horobin's most recent trade in Liquidia Corp was a trade of 18,396 Common Stock done . Disclosure was reported to the exchange on June 17, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Liquidia Corp
Joanna Horobin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2025 18,396 38,755 (0%) 0% 0 Common Stock
Liquidia Corp
Joanna Horobin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jun 2024 20,359 20,359 (0%) 0% 0 Common Stock
Kymera Therapeutics Inc
Joanna Horobin Director 07 Jun 2024 8,500 8,500 - 2.1 17,680 Common Stock
Kymera Therapeutics Inc
Joanna Horobin Director 07 Jun 2024 8,500 33,195 - - Stock Option (Right to Buy)
Kymera Therapeutics Inc
Joanna Horobin Director 07 Jun 2024 6,313 0 - 33.1 209,005 Common Stock
Kymera Therapeutics Inc
Joanna Horobin Director 07 Jun 2024 2,187 6,313 - 32.6 71,395 Common Stock
Liquidia Corp
Joanna Horobin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jun 2023 20,000 20,000 - - Non-Qualified Stock Option (right to buy)
Kymera Therapeutics Inc
Joanna Horobin Director 15 Jun 2023 12,000 12,000 - - Stock Option (Right to Buy)
Liquidia Corp
Joanna Horobin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2022 20,000 20,000 - - Non-Qualified Stock Option (right to buy)
Kymera Therapeutics Inc
Joanna Horobin Director 15 Jun 2022 12,000 12,000 - - Stock Option (Right to Buy)
Liquidia Corp
Joanna Horobin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Aug 2021 20,000 20,000 - - Non-Qualified Stock Option (right to buy)
Kymera Therapeutics Inc
Joanna Horobin Director 16 Jun 2021 20,063 20,063 - - Stock Option (Right to Buy)
Liquidia Corp
Joanna Horobin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Mar 2021 35,872 35,872 - - Non-Qualified Stock Option (right to buy)
Kymera Therapeutics Inc
Joanna Horobin Director 20 Aug 2020 40,127 40,127 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades